Skip to main content
logo
Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · Real-Time Price · USD
16.30
-0.38 (-2.28%)
Sep 25, 2026, 4:00 PM EDT - Market closed

Janux Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
9978303,087495547821
Market Cap Growth
-27.40%-73.11%523.34%-9.51%-33.35%-
Enterprise Value
47-1362,452170233434
Last Close Price
16.3013.8053.5410.7313.1719.73

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
41.5283.00291.5461.2763.54225.73
PB Ratio
1.070.873.021.441.712.24
P/TBV Ratio
1.070.873.021.441.712.24

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
1.94-231.6021.0827.00119.25

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.020.020.020.070.080.00
Net Debt / Equity Ratio
-1.02-0.99-0.98-0.93-0.94-1.02
Net Debt / EBITDA Ratio
6.716.0710.354.504.5511.42
Net Debt / FCF Ratio
22.6611.3422.696.096.1120.30
Asset Turnover
0.020.010.020.020.020.02
Quick Ratio
16.2538.9259.0326.5619.8529.32
Current Ratio
16.3539.0459.2126.8020.1429.46
Return on Equity (ROE)
-10.70%-11.48%-10.09%-17.53%-18.36%-17.50%
Return on Assets (ROA)
-8.80%-9.55%-8.57%-12.25%-11.27%-10.39%
Return on Capital Employed (ROCE)
-15.20%-16.10%-9.50%-19.90%-19.30%-9.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-10.29%-13.69%-2.23%-11.77%-11.52%-3.98%
FCF Yield
-4.21%-10.03%-1.43%-10.59%-9.02%-2.25%
Buyback Yield / Dilution
-6.20%-15.28%-22.12%-6.14%-76.24%-2471.20%
SEC Filings: 10-K · 10-Q